For the Inventor, By the Inventor

Enter assignee name

Oklahoma City, OK, United States of America

Urocor, Inc.

USPTO Granted Patents = 13

Trademarks = 1

Forward Citations = 553

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Robert W Veltri (9 out of 15 patents)

Gang An (8 out of 9 patents)

David Ralph (4 out of 4 patents)

4. S Mark O'Hara (4 out of 4 patents)

5. Kaveh Ashenayi (2 out of 6 patents)

6. David W Russell (2 out of 13 patents)

7. Anice E Thigpen (2 out of 6 patents)

8. Robert W Vertri (2 out of 2 patents)

9. Ying Hu (1 out of 1 patent)

10. Gerard J O'Dowd (1 out of 1 patent)

11. M Craig Miller (1 out of 2 patents)

12. Michael P Bacus (1 out of 2 patents)

13. Garry M Marley (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 7332270 - Diagnosis of disease state using mRNA profiles in peripheral leukocytes (2008-02-19),

2. 6463438 - Neural network for cell image analysis for identification of abnormal cells (2002-10-08),

3. 6369195 - Prostate-specific gene for diagnosis, prognosis and management of prostate cancer (2002-04-09),

4. 6218529 - Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer (2001-04-17),

5. 6190857 - Diagnosis of disease state using MRNA profiles in peripheral leukocytes (2001-02-20),

6. 6171796 - Biomarkers and targets for diagnosis prognosis and management of prostate disease (2001-01-09),

7. 6156515 - Prostate-specific gene for diagnosis, prognosis and management of (2000-12-05),

8. 6090559 - Biomarkers for the detection of prostate cancer (2000-07-18),

9. 5989811 - Sextant core biopsy predictive mechanism for non-organ confined disease (1999-11-23),

10. 5972615 - Biomarkers and targets for diagnosis, prognosis and management of (1999-10-26),

11. 5882864 - Biomarkers and targets for diagnosis, prognosis and management of (1999-03-16),

12. 5861248 - Biomarkers for detection of prostate cancer (1999-01-19),

13. 5856112 - Method for selectively inducing biomarker expression in urologic tumor (1999-01-05),

Company Overview

Urocor, Inc. is a specialized medical technology company based in Oklahoma City, Oklahoma. The organization focuses on developing innovative diagnostic and therapeutic solutions primarily for urological conditions. Urocor's expertise lies in enhancing patient care through advanced medical devices and laboratory services, contributing to improved outcomes in urology. The company is committed to research and development, aiming to address unmet clinical needs in the urological field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#23 in Oklahoma City, OK

#112 in Oklahoma

#23,854 in US

#45,081 in the World

Oklahoma City, OK, United States of America

Urocor, Inc.

Forward Citations = 553

13 inventors:

Robert W Veltri (9 out of 15 patents)

Gang An (8 out of 9 patents)

David Ralph (4 out of 4 patents)

4. S Mark O'Hara (4 out of 4 patents)

5. Kaveh Ashenayi (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Urocor, Inc.. Retrieved from https://idiyas.com/company/urocor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…